BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

European Commission (EC) Puts Out $187 Million to Fund 26 Research Projects


3/5/2013 12:51:09 PM

The European Commission will provide €144 million of new funding for 26 research projects, with the objective to deliver 200 new therapies for rare diseases by 2020, the EU's executive announced today (28 February). The projects, announced on Rare Disease Day 2013, is expected to help improve the lives of some of the 30 million Europeans suffering from a rare disease. The goal is to pool resources and work beyond borders in order to get a better understanding of rare diseases and find adequate treatments. The Commission is hoping that the projects, which will be conducted together with national and international partners, will deliver 200 new therapies for rare diseases and the means to diagnose most of them by 2020. Over 300 participants from 29 countries in Europe and beyond will be brought together in the selected projects, including teams from leading academic institutions, smaller businesses and patients' groups. "Most rare diseases affect children and most of them are devastating genetic disorders resulting in greatly reduced quality of life and premature death," said Máire Geoghegan-Quinn, the EU Commissioner for Research, Innovation and Science. "We hope that these new research projects will bring patients, their families and health professionals closer to a cure and support them in their daily battle with disease," she said in a statement.

Read at EurActiv

EurActiv
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES